BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16194572)

  • 1. HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice.
    Khare M; Mangalam A; Rodriguez M; David CS
    J Neuroimmunol; 2005 Dec; 169(1-2):1-12. PubMed ID: 16194572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
    Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
    J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice.
    Mangalam AK; Khare M; Krco C; Rodriguez M; David C
    Eur J Immunol; 2004 Jan; 34(1):280-90. PubMed ID: 14971054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
    Chou YK; Culbertson N; Rich C; LaTocha D; Buenafe AC; Huan J; Link J; Wands JM; Born WK; Offner H; Bourdette DN; Burrows GG; Vandenbark AA
    J Neurosci Res; 2004 Sep; 77(5):670-80. PubMed ID: 15352213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
    Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
    J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.
    Klehmet J; Shive C; Guardia-Wolff R; Petersen I; Spack EG; Boehm BO; Weissert R; Forsthuber TG
    Clin Immunol; 2004 Apr; 111(1):53-60. PubMed ID: 15093552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class II transgenic mice mimic human inflammatory diseases.
    Mangalam AK; Rajagopalan G; Taneja V; David CS
    Adv Immunol; 2008; 97():65-147. PubMed ID: 18501769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.
    Rich C; Link JM; Zamora A; Jacobsen H; Meza-Romero R; Offner H; Jones R; Burrows GG; Fugger L; Vandenbark AA
    Eur J Immunol; 2004 May; 34(5):1251-61. PubMed ID: 15114658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma.
    Mangalam A; Luckey D; Basal E; Behrens M; Rodriguez M; David C
    J Immunol; 2008 Jun; 180(11):7747-56. PubMed ID: 18490779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice.
    Mangalam A; Rodriguez M; David C
    Eur J Immunol; 2006 Dec; 36(12):3356-70. PubMed ID: 17125142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
    Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice.
    Mangalam A; Luckey D; Basal E; Jackson M; Smart M; Rodriguez M; David C
    J Immunol; 2009 Apr; 182(8):5131-9. PubMed ID: 19342694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
    Finn TP; Jones RE; Rich C; Dahan R; Link J; David CS; Chou YK; Offner H; Vandenbark AA
    J Neurosci Res; 2004 Oct; 78(1):100-14. PubMed ID: 15372502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis.
    Khare M; Rodriguez M; David CS
    Int Immunol; 2003 Apr; 15(4):535-46. PubMed ID: 12663683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis.
    Ford ML; Evavold BD
    Eur J Immunol; 2004 Feb; 34(2):388-97. PubMed ID: 14768043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
    Samoilova EB; Horton JL; Chen Y
    Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein.
    Irony-Tur-Sinai M; Grigoriadis N; Lourbopoulos A; Pinto-Maaravi F; Abramsky O; Brenner T
    Exp Neurol; 2006 Mar; 198(1):136-44. PubMed ID: 16423348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.